Age: 45.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hyperhidrosis, Loss of consciousness
Clinical narrative: DEATH; LOSS OF CONSCIOUSNESS; DIFFICULTY BREATHING; SWEATY; WEAK; DIARRHEA; DIZZINESS; This spontaneous report received from a physician concerned a 45 year old male. The patient's weight was 273 pounds, and height was not reported. The patient's past medical history included allergy to vancomycin, and constipation, and concurrent conditions included hypertension, hypothyroidism, hyperlipidemia, and bipolar. The patient was previously treated with amlodipine besilate for hypertension, atorvastatin calcium for hyperlipidemia, levothyroxine for hypothyroidism, fluoxetine hydrochloride for bipolar, risperidone for bipolar, venlafaxine hydrochloride for bipolar, magnesium citrate for constipation, and lactulose for constipation. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, and expiry: UNKNOWN) dose was not reported, 1 total administered on 07-APR-2021 on right deltoid for prophylactic vaccination. The patient had no reaction to the vaccine at the time No concomitant medications were reported. On 09-APR-2021 at 09:02, the patient was sweaty, weak, and had difficulty breathing. The patient had diarrhea and dizziness. The patient was placed on the ground by the nurse as he lost consciousness and started CPR at 9:22am; 911 was alerted. The subject was treated with cardiopulmonary resuscitation and automated external defibrillator was initiated at 9:35 with no shockable rhythm for 45 minutes while cardiopulmonary resuscitation has been done. On 09-APR-2021 09:55, treatment medications included: two shots of epinephrine given by the paramedics and the patient was placed in the ambulance. On 09-APR-2021 10:06, the patient was deceased. An autopsy was performed on 09-APR-2021. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died from an unknown death on 09-APR-2021, and the outcome for diarrhea, dizziness, difficulty breathing, loss of consciousness, sweaty and weak was unknown. This report was serious (Death, and Other Medically Important Condition).; Sender's Comments: V0 This report concerns a 45-year-old male patient (273 pounds) who died two days after receiving Janssen COVID-19 vaccine.  Patient medical history included allergy to vancomycin, constipation, hypertension, hypothyroidism, hyperlipidemia, and bipolar. The patient received Jansen COVID-19 vaccine and had no reaction at the time.  Two days after vaccination in the morning, at 9:02 patient complained about feeling sweaty, weak, dizziness, and had diarrhea and difficulty breathing. Twenty minutes later (9:22), he was found unconscious. CRP was started and 911 was called.  AED was initiated at 9:35 with no shockable rhythm for 45 minutes. Two shots of epinephrine were given in the ambulance. The patient was pronounced died at 10:06.  It was unknow whether an autopsy was performed.  Based on the reported information, patient's overweight and comorbidities (hypertension, hypothyroidism, and hyperlipidemia) were most likely the cause of his death. Additional information has been requested, including autopsy findings.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH